Abstract: We used cost-effectiveness analysis to estimate the health and economic implications of exercise in preventing coronary heart disease (CHD). We assumed that nonexercisers have a relative risk of 2.0 for a CHD event. Two hypothetical cohorts (one with exercise and the other without exercise) of 1,000 35-year-old men were followed for 30 years to observe differences in the number of CHD events, life expectancy, and quality-adjusted life expectancy. We used jogging as an example to calculate cost, injury rates, adherence, and the value of time spent. Both direct and indirect costs associated with exercise, injury, and treating CHD were considered. We estimate that exercising regularly results in 78.1 fewer CHD
Introduction
Regular aerobic exercise is increasingly being viewed by health professionals as a key behavioral ingredient in reducing the risk of illness, particularly illness associated with heart disease. The "fitness craze" has emerged as an integral component of the broader concern with health promotion, with exercise explicitly recognized in the US Public Health Service's health promotion and disease prevention objectives for the nation.1 In recent years the presumed cardiovascular benefits of exercise have received convincing empirical support.2" Accordingly and increasingly, the medical profession has come to recognize and prescribe exercise as a preventive and rehabilitative therapy.
Many health promotion advocates emphasize also the economic benefits of exercise, in addition to its contribution to better health.5 Because both the economic and medical dimensions ofexercise are subjects of substantial interest, we examine the cost-effectiveness of exercise as a primary prevention medical technology. Our interests are in the health and economic implications of exercise as compared with its absence and in using exercise as an alternative to common medical interventions designed to address potential or existing heart disease. In addition, we examine the issue of whether exercise consumes more or less time than it saves in increased life expectancy.
Methods
We used decision analysis and cost-effectiveness analysis to compare a regular exercise regimen with its absence in cohorts of 1,000 35-year-old men, followed for 30 years. We defined exercise as leisure time physical activity that consumes 2,000 kcal per week. Jogging was used as an events We have also considered an alternative (voluntary) approach, which ultimately would target the exercise program at those who consider it to be enjoyable, or are at least neutral. We assumed that persons who start exercising do so for a one-year trial. After that, those who like it or are neutral continue, whereas those who do not like it quit permanently. We used probabilities of liking or disliking exercise derived from the expert survey and applied the same cost assumptions.
Analysis of Time Trade-Off
Recent critiques of analysis of the life expectancy benefits of exercise have commented that exercisers consume as much time in exercise as they gain in life expectancy.'3 To examine this issue and to provide another perspective, we determined the balance between time spent on exercise and injuries and that gained from CHD prevention. In effect, this approach constitutes a time cost-benefit analysis of exercise. We used the same assumptions as in the base case cost-effectiveness analysis.
Results

Health Benefits of Exercise
Under the base case assumptions there were 78.1 fewer CHD events in the exercise cohort than in the nonexercisers (Table 1) 
Discussion
Previous studies have concluded that other disease prevention technologies are cost-effective relative to therapeutic health care expenditures,'4 and sometimes even produce net economic savings, e.g., fluoridation15 and certain immunizations.16"7 Recently, however, concern has been expressed that, in some instances, preventive measures for chronic illnesses may be less cost-effective than those for acute conditions, and further that preventive measures are not invariably more cost-effective than curative therapy. '8 On the basis of our estimates and assumptions, exercise is a cost-effective approach to lowering the risk of CHD. emphasized, however, that these studies include direct costs only. It is conceivable that if these other CHD interventions saved a sufficient amount of productivity, then the inclusion of indirect benefits and costs would make these interventions more cost-effective. The other cost-effectiveness studies of CHD interventions use only direct costs and savings, as is customary in cost-effectiveness analysis. We consider the indirect costs of time spent in exercise to be integral to this health intervention. An alternative approach to expressing cost-effectiveness could apply both direct and indirect costs but only direct benefits (our base case uses both direct and indirect benefits). This method results in a cost of $30,575 per QALY saved, or $75,232 per year of life saved. For the voluntary approach, exercise, which was cost saving when both direct and indirect costs and benefits were used, no longer saves money but is cost-effective at $9,180 per QALY saved, when total costs and only direct benefits are used. Thus even using this conservative approach, exercise remains comparable in costeffectiveness to other CHD interventions. Significantly, evaluations of the costs of treatment of morbid conditions typically do not quantify the nonpecuniary costs of the disease and its treatment (i.e., the costs ofpain and suffering).
The indirect cost of exercise is the most important variable in influencing the results of this analysis. If the indirect cost (time spent in exercise) were valued as "no cost", then exercise would be cost-saving. However, we treat exercise time as having opportunity cost. Although the wage rate is commonly used in economic studies as the value of leisure time, we used one-half the wage rate as our basic measure of this opportunity cost. Both theory and empirical analysis suggest that the opportunity cost of the marginal leisure hour is less than the wage rate. We have used the estimate of half the wage rate produced by one of the few studies to examine this issue empirically.t9 Note that our treatment of the indirect cost of time for those who enjoy exercise is undoubtedly conservative for many people who are (or would be) willing to pay to exercise (as demonstrated by memberships in health clubs, for example). To these people, the benefits of exercise-immediate and perceived for the future-give exercise a net positive economic value.
Our results support an approach in which physicians would strongly urge patients to begin an exercise program on a trial basis for one year, with the expectation that only those persons who find it pleasurable or those who are neutral would be encouraged to continue. Such an approach was found to yield net cost savings, whereas an all-or-nothing approach in which "exercise-haters" are forced (in the model) to comply was cost-ineffective for this group ($48,775/ QALY) compared with other methods of coronary heart disease prevention ($5,000 to $30,000 per QALY).
Our study focused on only cardiovascular health benefits of exercise. Other demonstrated health benefits of exercise include weight control, stress reduction, smoking cessation, and assistance in diabetes and hypertension management.20 Quantification and inclusion of these benefits would improve the relative cost-effectiveness of exercise, possibly considerably.
Other forms of exercise also provide aerobic cardiovascular benefits. If used in a similar analysis, walking, swimming, and bicycling would require changing several variables. For example, walking might be a more enjoyable pastime for certain participants, thus lowering the indirect costs of exercise, but walking would require more time to achieve the same cardiovascular benefit, thereby increasing To perform this analysis we have had to make several assumptions and use the best available data. The analysis can be improved in the future as more knowledge is gained on exercise and CHD, and then applied in a systematic and analytic framework.
For persons who enjoy the immediate pleasure and benefits of exercise, this activity is probably also a costeffective measure in reducing risks of CHD. For others who find exercise a less pleasant activity, its cost-effectiveness is comparable to that of some drug therapies and surgical interventions. 12 Most persons logically would prefer to prevent a morbid condition rather than develop it and have it treated. However, they may require more immediate satisfaction to undertake and maintain a regular exercise regimen than the knowledge that it will reduce their long-term risk of CHD or that it is "cost-effective."
